The Trump administration is expected to keep drug pricing on center stage in 2019 following a flurry of action last year. In 2018, the administration released a 44-page blueprint with ideas and questions on potential ways to lower drug prices and reduce out-of-pocket costs, and HHS, FDA and CMS proposed a torrent of regulations and notices. The pace in 2019 shows no sign of slowing as more information emerges about current proposals and officials continue to introduce new ideas. Overall,...